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DiseaseAbstract In the past two decades, calcium oxalate urolithiasis (COU) has been a frustrating prob-
lem worldwide. Several recent studies, indicate that the macromolecules are of greater importance
to the inhibitory effects on crystal growth and aggregation. Various macromolecules modulate var-
ious steps of stone formation. Osteopontin and Tamm-Horsfall glycoprotein are two important
proteins involved in the process of retention of crystals and stone formation. Osteopontin is a
potent inhibitor of crystallization of calcium phosphate and calcium oxalate, the most common
crystals found in the urine and kidney stones. On the other side it is a multifunction protein. It
is involved in divers’ biological processes. Tamm-Horsfall glycoprotein modulates aggregation
and growth of supersaturated salts and their crystals, respectively. It in addition contributes to
the colloid osmotic pressure of urine, helping to prevent urinary tract infections. The aim of this
review is to outline some important aspects of these two macromolecules especially regarding renal
stone diseases.
ª 2014 The Egyptian German Society for Zoology. Production and hosting by Elsevier B.V. All rights
reserved.Contents
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Stone inhibitors are deﬁned asmolecules that increase the super-
saturation required to initiate nucleation, decrease crystal
growth and aggregation to inhibit secondary nucleation (Chan
et al., 2012). Stone inhibitors could be divided into low molecu-
lar weight inhibitors (magnesium and citrate) and macromole-
cules (some amino acids and proteins). The intra-crystalline
proteins assist in the dismantling and dissolution of internalized
crystals and thereby provide a natural defense against stone
pathogenesis. This notion is supported by qualitative studies
and quantitative data conﬁrming that urinary COM crystals
are degraded and dissolvedmore rapidly than inorganic crystals
(Chauvet and Ryall, 2005). There is also indirect evidence that
urinary macromolecules are actively involved in CaOx crystal
formation at the point of nucleation, since fractured urinary
COM crystals clearly contain organic material concentrated at
their centers (Bushinsky et al., 2002). Although they provide a
means of removing obstructing crystals from the tubular lumen
and then destroying them completely inside the cell, but in the
same time macromolecules can promote attachment of cells to
the urothelium by assisting in crystal endocytosis thus, intra-
renal ﬁxation of crystals – a prerequisite for stone formation –
so macromolecules appear to play a paradoxical role in stone
formation.Ofmanyurinarymacromolecules two are considered
to be of high important value osteopontin (uropontin) and
Tamm-Horsfall protein (uromodulin).
Although these two proteins were discovered long time ago,
yet their role in setting kidney stone formation is not fully
investigated (Lieske et al., 1995). Therefore, in this review,
we brieﬂy considered the approaches used by different col-
leagues in the literature to uncover the nature and mechanisms
that linked the OPN and THP proteins to the process of renal
oxalosis. We also tried to answer some questions such as: (1)
What is the nature, physiology and regulation of THP and
OPN proteins in normal renal functions? (2) How the expres-
sion of THP and OPN changes in cases of renal oxalosis? In
the same vein, we try to highlight a number of selected exper-
iments and concepts that we consider of particular interest to
molecular biologists in the ﬁeld of molecular diagnosis of renal
stones and oxalosis.Tamm-Horsfall protein
Regulation and physiological functions of THP
Tamm-Horsfall protein (THP) is a unique glycoprotein because
it is exclusively expressed in the kidney, especially in thick
ascending limbs (TALs) and early distal tubules (Cavallone
et al., 2001). THP is a protein selectively expressed by epithelial
cells of the thick ascending limb of Henle’s loop (TALH).
Normally, the synthesized protein is translocated into theendoplasmic reticulum (ER), glycosylated, glycosylphosphat-
idylinositol (GPI) – anchored and secreted into the apical tubular
cellmembrane (Kreft et al., 2002).The released protein is excreted
in the urine and represents themost abundant urinary protein in a
healthy individual. In urine, the protein precipitates and is the
main constituent of hyaline urinary casts (Khan, 1997).
Although this glycoprotein was discovered more than
60 years its functions are still not fully understood (Sodhi
et al., 2001). Following THP shedding from the apical mem-
brane of TALH cells, massive amounts of THP are released
into the tubular ﬂuid. One can imagine that the released pro-
tein maintains its gel-like or molecular sieve-like structures,
interacting or associating with other THP molecules, which
are still plasma membrane anchored. This structure may form
a slowly moving polyanionic gel potentially serving several
advantageous functions. It may contribute to the colloid
osmotic pressure and retard passage of positively charged elec-
trolytes (sodium and potassium) through the TALH and thus
enhance their active transport and reabsorption in this segment
(Vyletal et al., 2010).
In the case of THP, this probably promotes formation of
complex ﬁlamentous gel-like structures, providing the water
barrier on the luminal plasma membrane of TALH cells and
serving as a physical barrier to water permeability. Such a bar-
rier may play an important role in ion transport and mainte-
nance of countercurrent gradient in the interstitium (Hoyer
et al., 1979).
Due to the GPI-enriched endocytic compartments
(Sabharanjak et al., 2002; Kirkham et al., 2005) some studies
hypothesized that THP may serve as a receptor for binding
and endocytosis of yet to be deﬁned ligands (cytokines, TNF,
etc.). This may also play a role in the modulation of cell surface
events, receptor engagement and signal transduction along the
corresponding nephron segment. THP localizes to cilia
(Zaucke et al., 2010) which suggests that it may contribute to
mechano-sensation of urinary ﬂow, cell cycle regulation andpla-
nar cell polarity. Recently THP was thought to be an important
factor for up-regulation of inﬂammatory chemokines especially
when involved in acute renal injury (El-Achkar et al., 2011).
Mutation of the THP gene reduces ciliary expression due to
disorganized trafﬁcking and its retention inside the endoplasmic
reticulumwhich ﬁnally results in decreased THP secretion in the
urine (Rampoldi et al., 2011). THP gene mutation is related to
some diseases in humans such asmedullary cystic kidney disease
type 2 and familial juvenile hyperuricemic nephropathy that is
autosomal dominant tubule-interstitial kidney.The role of THP in CaOx crystal aggregation
Depending upon ambient conditions and methodology, THP
exhibits a frustrating range of effects on CaOx crystallization
as it is believed to be an effective inhibitor for COM crystal
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low concentration of divalent ions. Although there are many
reports that THP has no effect on CaOx deposition in syn-
thetic inorganic media (Grover et al., 1998) it has been
reported to inhibit deposition of CaOx (Hullinger et al.,
2001). In urine, however, it promotes both CaOx precipitation
since low pH, high concentrations of calcium, sodium, and
hydrogen ions reduce the inhibitory activity of THP and it
may even become a promoter of aggregation (Grover et al.,
1990). THP when isolated from the urine of recurrent kidney
stones formation of calcium oxalate crystals indicated that
THP has a self-aggregation to be of greater degree than the
inhibitory effect. Nonetheless, it is a potent inhibitor of CaOx
crystal aggregation in undiluted, ultraﬁltered urine. For the
crystal–cell interaction Lieske et al. (1997) reported that the
protein has no inﬂuence on crystal–cell interaction. Meanwhile
others recorded that it inhibits crystal adhesion to cultured
renal cells, and also protects against oxalate-induced radical
injury in MDCK cells, which has been attributed, at least in
part, to its degree of glycosylation and its ability to adhere
to the cell membrane (Hsieh et al., 2003).THP expression in renal stone formation
Initial hybridization studies showed that THP mRNA is only
expressed in the kidney (Pennica et al., 1987). In this organ,
THP is distributed to the cells lining the thick ascending limb
(TAL) of Henle’s loop, with an extension to the early distal
convoluted tubule (DCT) in some species (Seraﬁni-Cessi
et al., 2003).
The chronicmodel of nephrolithiatic kidneys expressed THP
as darkly stained matrix closely associated with the crystal
deposits in the cortical and medullary regions. Furthermore, it
was seen that positive staining for THP in the papilla was signif-
icantly pronounced in kidneys with extensive crystal deposition
(Gokhale et al., 1997). In the same study, the semi-acute model,
THP appeared in the papilla, coincided with the formation of
crystal deposits in the kidney and when a few crystals were seen
in the sections, some papillary tubules stained positive for THP.
In addition, some of the renal tubules contained deposits of the
darkly stained matrix-like material, without any evidence of
crystals. Strong expression of THP in lithogenic rats was
induced not by crystals, but by renal tubular damage caused
by tubular dilatation, leading to speculation that THP might
promote stone formation by acting as a crystal adhesive which
again seems at odds with its inability to bind irreversibly to
CaOx crystal (Ryall et al., 2007). Surprisingly, low levels of
THPwere detected in the kidneys of ethylene glycol treated rats,
as a few tubules were positively immunostained when compared
to the control group (Grover et al., 1998). THP knock-out mice
showed dense intra-tubular crystal aggregates. These crystals
were not only located primarily in the collecting ducts in deep
medulla and renal papillae, with some of the crystals clearly
attached to the luminal surfaces of the tubular epithelial cells,
but also theTHPdeﬁciency dramatically increased susceptibility
of mice to experimentally induced renal crystal formation (Mo
et al., 2004).
In normal dogs’ kidneys, THP was expressed in the cells lin-
ing the thick ascending limb of loop of Henle (TAL) in the
outer medulla and cells lining the distal convoluted tubules
in the renal cortex as this immunoreactive substance wasabsent in all other renal structures, the entire epithelium was
intensely stained but there was a high concentration in the api-
cal membrane and in the distal convoluted tubules, positive
cells were scattered throughout the epithelium and had a
homogenous immunoreactivity (Riala et al., 2003). In the same
stream THP was expressed in normal canines’ kidneys and
found that the distribution on the epithelia of the TAL in
the loop of Henle was intensely stained, while there was less
intense staining along the cells lining the DCT. THP was
expressed along the apical border of the epithelial cells in both
the TAL and DCT. There was also diffuse cytoplasmic stain-
ing in these cells. Nuclei did not stain positively for THP, or
any other region of the nephron (Brandt et al., 2012).
Another description of THP positive cells distribution is
that they were present in the cortex and in the medulla of
the kidney of normal control dogs in the cortical labyrinth,
scattered tubules, stained positive with THP protein. Most
tubules of the outer medulla stained positive with THP, but
in the inner medulla, only rare scattered cells in a few tubules
were positively stained (Bauchet et al., 2011).
Osteopontin
OPN is a negatively charged acidic hydrophilic protein of
approximately 300 amino acid residues, and is secreted into
all body ﬂuids. OPN has an arginine–glycine–aspartic acid
(RGD) cell binding sequence, a calcium binding site and two
heparin binding domains. Cells may bind OPN via multiple
integrin receptors including the vitronectin receptor (avb3) as
well as various b1 and b5 integrins. Integrin binding may be
RGD-dependent or -independent (e.g. via the motif
SVVYGLR). OPN does not bind the standard form of CD44
(hyaluronic acid receptor) but does bind various isoforms of
CD44. These CD44 isoforms bind OPN via multiple sites.
OPN may be cleaved by thrombin, resulting in the exposure
of additional cryptic binding sites as well as the production of
functional chemotactic fragments (O’Regan et al., 1999).
Regulation of OPN expression
The regulation of OPN expression is incompletely understood
at present and may differ between various cell types. Studies
indicate that the OPN promoter contains various motifs
including a purine-rich sequence, glucocorticoid and vitamin
D response elements and interferon inducible elements
(Koszewski et al., 1996). Pro-inﬂammatory cytokines stimulate
OPN gene transcription and expression. For example, activa-
tion of macrophages with lipopolysaccharide (LPS) and nitric
oxide (NO) induces OPN gene expression and protein secre-
tion. Seven classical mediators of acute inﬂammation such as
tumor necrosis factor a (TNFa) and interleukin-1b (IL-1b)
strongly induce OPN expression (50) while other mediators
that might induce OPN upregulation include angiotensin II,
transforming growth factor b(TGFb), hyperglycemia and
hypoxia (Hullinger et al., 2001; Sodhi et al., 2001).OPN and pathological mineralization
OPN is intimately involved in the regulation of both physio-
logical and pathological mineralization. In normal bone tissue,
Osteopontin and Tamma-Horsefall proteins 161OPN is expressed by both osteoclasts and osteoblasts which
are the cells responsible for bone remodeling. During normal
bone mineralization, osteoclast derived OPN inhibits the for-
mation of hydroxyapatite (Hunter et al., 1994).
OPN is an important facet of the urinary tract’s defense
against the formation of renal stones, the majority of which
are comprised of calcium oxalate. As a consequence of the
essential homeostatic conservation of water, normal urine is
supersaturated with respect to crystalline components, and this
empirically suggests the existence of physiological mechanisms
that actively inhibit urinary crystallization of calcium salts.
Various inhibitory macromolecules including urinary OPN
have now been isolated and identiﬁed from both normal urine
and kidney stones, e.g. nephrocalcin, crystal matrix protein,
bikunin and THP (Hullinger et al., 2001).
OPN is synthesized within the kidney and secreted into the
urine by epithelial cells, including the loop of Henle, distal con-
voluted tubule and papillary epithelium (Giachelli et al., 1994).
OPN can inhibit the nucleation, growth and aggregation of
calcium oxalate crystals in vitro (Worcester and Beshensky,
1995) and directly inhibits the binding of calcium oxalate crys-
tals to cultured renal epithelial cells. In addition, OPN directs
calcium oxalate crystallization to the calcium oxalate dihy-
drate phase, which is signiﬁcantly less adherent to renal tubu-
lar epithelial cells than the calcium oxalate monohydrate phase
(Wesson and Worcester, 1996; Wesson et al., 1998).
Experiments involving hyperoxaluric rats that develop renal
calcium oxalate deposition do suggest an important in vivo role
of OPN, since the upregulation of OPN mRNA and protein
expression speciﬁcally co-localized with areas of renal calcium
oxalate deposition (Jiang et al., 1998). However, deﬁnitive data
regarding the protective role of OPN were lacking until
recently. OPN knockout mice were used to test the hypothesis
that OPN is required for the effective prevention of renal cal-
cium oxalate deposition in vivo (Hoyer et al., 2001). In a com-
parable study hyperoxaluria was induced in OPN knockout
and control OPN wild-type mice by the administration of 1%
ethylene glycol, an oxalate precursor, in drinking water for
4 weeks. Hyperoxaluric OPN knockout mice developed signif-
icant intratubular deposition of calcium oxalate while OPN
wild-type mice were completely unaffected. Crystal inclusions
were comprised exclusively of calcium oxalate monohydrate,
and typically affected the distal nephron and collecting duct,
sites where the concentration of oxalate would be predicted
to be the highest. Interestingly, the absence of calcium oxalate
deposition in hyperoxaluric OPN wild type mice was associated
with signiﬁcant upregulation of renal OPN expression by
immunocytochemistry, thereby lending further support for a
renoprotective role for OPN (Mazzali et al., 2002).
The fact that OPN knockout mice do not spontaneously
develop renal calcium oxalate deposition indicates that other
urinary inhibitors can adequately compensate for the absence
of OPN. However, these studies do indicate that urinary
OPN is essential in adverse conditions predisposing to calcium
oxalate deposition. OPN-mediated protection is likely to result
from effects at various sites along the pathway of crystal for-
mation, growth and retention. Currently, the exact molecular
mechanism whereby OPN exerts its various inhibitory effects
is unclear, although it is known that phosphorylation of the
OPN molecule is critically important (Hoyer et al., 2001).
It is noteworthy that OPN is present in normal urine at lev-
els that can effectively inhibit crystallization (Chan et al., 2012).In humans, clinical studies to date are inconclusive regarding
the relationship between OPN and renal stone disease. OPN
may play an important role in protecting the kidney from stone
formation. Immunohistochemical staining with three different
anti sera to mouse OPN, revealed that OPN expression in the
normal mouse kidney is primarily restricted to the thick ascend-
ing limbs of the loop of Henle and distal convoluted tubules.
The protein is detected predominantly at the apical surface of
cells lining the lumen of a subset of tubules. OPN expression
is not detected in healthy glomeruli, proximal tubules, thin
limbs of the loop of Henle, collecting ducts, or interstitial ﬁbro-
blasts. OPNmRNA and protein were found to be markedly up-
regulated in the glomerular and tubular OPN expression was
strongly associated with macrophage accumulation and pro-
gressive renal injury and correlated with the development of
tubulitis, tubulointerstitial ﬁbrosis, proteinuria, and renal func-
tion impairment (Xie et al., 2001).
By analysis of OPN gene expression proﬁle in renal tubular
cells exposed to COM crystals to determine the relationship
between renal tubular cells and COM crystals, they exposed
normal rat epithelial cells, (NRK-52E) to already prepared
COM crystal suspension for 60 and 120 min. They found that
OPN was the only gene that had upregulated both after 60 and
120 min (Miyazawa et al., 2009). Khan (1997) documented
that after 2 weeks of treating rats with EG to induce CaOx
nephrolithiasis, kidneys showed an increase in staining over
those in untreated animals, although staining was still mostly
conﬁned to renal epithelial cells lining the loop of Henle and
cells on the surface of the renal papillary base and calyceal for-
nix, but after 8 weeks of treatment there was a remarkable
increase in the frequency and intensity of staining, which was
much more prominent and spread throughout the whole kid-
ney, including the tubules in the inner medulla and renal papil-
lae. They mentioned that the most intense staining was
associated with crystal deposits irrespective of the tubular seg-
ment. Similarly a few isolated tubules stained positive for oste-
opontin in controls. These tubules were often in the vicinity of
glomeruli. More tubules stained positive for osteopontin in
ethylene glycol treated rats, and these tubules were often in
large clusters and did not appear to be adjacent to glomeruli.
Crystals reacted positively with OPN.
OPN was expressed in the kidney of male Wistar rats
receiving drinking water supplemented with (0%, 0.5%, and
0.75%) ethylene glycol (EG) for 1, 4, and 8 days mentioned
that it was upregulated especially in the Golgi apparatus
immunostaining in proximal tubules and at the apical mem-
brane in distal tubules and they strongly suggest that crystal
retention in the kidney requires tubular epithelial injury
accompanied by luminal expression of OPN in addition to
other two proteins Hyaluronan (HA) and CD44 (Asselman
et al., 2003). In Vero cell (African green monkey renal epithe-
lial cell line) injury increases the OPN expression in the renal
cell surface and suggested that number of OPN molecules on
the surface of the cells increased signiﬁcantly after the injury
of cells had been aggravated (Ouyang et al., 2011).OPN and inﬂammation
OPN plays an important role during both acute and chronic
inﬂammation where it may be expressed by resident epithelial,
endothelial and smooth muscle cells as well as inﬁltrating
162 W.I. Mohamaden et al.macrophages and T cells. OPN may exert both pro-inﬂamma-
tory and anti-inﬂammatory actions, with the net effect of OPN
depending upon the nature of the biological scenario.
OPN is involved in the recruitment and retention of macro-
phages and T cells to inﬂamed sites. OPN expression correlates
with macrophage inﬁltration in various animal models of acute
and chronic renal injury such as glomerulonephritis, hyperten-
sive glomerulosclerosis and cyclosporine nephropathy
(Hartner et al., 2001). In addition, upregulation of OPN expres-
sion precedes the macrophage inﬁltrate present in injured kid-
neys (Lieske et al., 1995). An important functional role for
OPN in renal disease is supported by studies involving the
administration of function blocking anti-OPN antibodies in
rat models of acute glomerulonephritis.
Administration of intravenous OPN antisense oligodeoxy-
nucleotide to rats with glomerulonephritis resulted in decreased
OPN expression by tubular epithelial cells and diminished inter-
stitial macrophage accumulation (Okada et al., 2000). Studies
involving OPN knockout mice have produced somewhat con-
ﬂicting results, since the absence of OPN resulted in diminished
macrophage inﬁltration following ureteric obstruction but had
no effect uponmacrophage inﬁltration in amodel of glomerulo-
nephritis (Bonvini et al., 2000).
Conclusions
In conclusion, numerous attempts had been made to investi-
gate the nature and the mechanism of actions of the OPN
and THP proteins. THP gene expression, biosynthesis and
excretion are regulated in a complex manner and reﬂect a wide
range of pathological conditions. OPN is an impressively mul-
tifunctioning molecule that plays a role in the body defense
against renal crystals beside its role against the inﬂammatory
conditions in renal tissue. However it is envisaged that the
molecular mechanism of OPN and THP is still hiding a count-
less secretes that will reveal the pathogenesis of several diseases
such as renal stones, inﬂammation and cancers and that might
be promising for innovation of new therapeutic agents in the
future for these diseases. Future trends should be directed
toward more understanding of the molecular mechanisms
behind renal stone formation and cases of renal oxalosis.
Moreover, more strategies should be conducted to use the lev-
els of THP and OPN in renal tissues or even urine as a method
to judge the severity of occurrence of renal stones. Finally, a
therapeutic way should be carried out to use the two proteins
to treat cases of renal stones as they believe to reduce or even
inhibit crystal formation and aggregation.
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